About 1 in 5 patients hospitalized for exacerbations of chronic obstructive pulmonary disease (COPD) in the United States are readmitted within 30 days. The U.S. Centers for Medicare and Medicaid Services has recently expanded its Hospital Readmissions Reduction Program to financially penalize hospitals with higher than expected all-cause 30-day readmission rates following a hospitalization for COPD exacerbation. In October 2013, the COPD Foundation convened a multi-stakeholder National COPD Readmissions Summit to summarize our understanding of how to reduce hospital readmissions in patients hospitalized for COPD exacerbations. Over 225 individuals participated in the Summit, including patients, clinicians, health service researchers, policy makers and representatives of academic health care centers, industry, and payers. Summit participants recommend that programs to reduce hospital readmissions: 1) Include specific recommendations about how to promote COPD self-management skills training for patients and their caregivers; 2) Adequately address co-existing disorders common to COPD in care plans during and after hospitalizations; 3) Include an evaluation of adverse events when implementing strategies to reduce hospital readmissions; and 4) Develop a strategy (e.g., a learning collaboratory) to connect groups who are engaged in developing, testing, and implementing programs to reduce hospital readmissions for COPD and other conditions.
Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder characterized by persistent airflow obstruction and chronic respiratory symptoms in response to inhaled cigarette smoke or other irritants or a deficiency of alpha-1-antitrypsin. COPD is the third leading cause of death in the United States.
1 There are approximately 700,000 hospitalizations with the principal diagnosis of COPD in the United States each year, with 1 in 5 readmitted within 30 days.
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About half of the estimated $50 billion in annual health care expenditures for COPD has been attributed to costs associated with hospitalizations for COPD exacerbations.
6-8
In 2012, the Centers for Medicare and Medicaid Services (CMS) launched the Hospital Readmissions Reduction Program (HRRP) to reduce the risk of hospital readmissions in patients hospitalized for acute myocardial infarction, pneumonia, or heart failure. In 2014, the CMS HRRP was expanded to include hospitalizations for COPD exacerbations. The CMS HRRP uses financial penalties to motivate hospitals to develop, test, and implement quality improvement programs to reduce avoidable hospital readmissions within 30 days of hospital discharge. The CMS HRRP financial penalties can be as high as 3% of hospitalspecific Medicare payments for all discharges, not only payments related to the excess readmissions.
In October 2013, the COPD Foundation convened a multi-stakeholder National COPD Readmissions Summit to discuss readmissions in patients hospitalized for COPD exacerbations and the potential implications of adding COPD as a penalty-sensitive condition for the CMS HRRP. In this report, we summarize the discussions and recommendations from this Summit.
Participants in the National COPD Readmissions Summit
The COPD Foundation established a planning committee to identify potential speakers ( Table 1) . The Planning Committee invited representatives of several evidence-based programs designed to reduce hospital readmissions (Project Re-Engineered Discharge, Transitional Care Model, The Care Transitions Program, and Project Better Outcomes by Optimizing Safe Transitions).
9-12 The Planning Committee also invited experts on the HRRP and interventions to reduce hospital readmissions in patients with COPD exacerbations. A representative of the Patient-Centered Outcomes Research Institute (PCORI) was invited to discuss the role of PCORI in funding studies addressing the expressed needs of patients and caregivers regarding hospital readmissions.
The workshop included in-person and online participants, who were encouraged to pose questions to the speakers. Over 225 participants attended the National COPD Readmission Summit, representing over 65 organizations. A diverse group of individuals participated in the Summit, including patients, clinicians, health service researchers, policy makers and representatives of academic health care centers, industry (pharmaceutical, durable medical equipment), and payers.
Epidemiology of Readmissions in Patients With COPD Exacerbations
The quality of care for patients hospitalized for COPD exacerbations varies, as does the risk of readmissions and mortality following hospital discharge in this population.
8,13,14
In a study published in 2006, patients hospitalized for COPD exacerbations received only about 50% of the care recommended by guidelines.
15 In a subsequent study conducted by the multicenter National Heart Lung and Blood Institute COPD Outcomes-based Network for Clinical Effectiveness and Research Translation (CONCERT), gaps in guideline-recommended care were most evident for instructing patients about how to use respiratory inhalers (approximately 20% received instruction about use of respiratory inhalers, range 0% to 85% across 6 sites) and providing a post-discharge appointment for follow-up care (50% had a post-discharge appointment prior to hospital discharge, range 20% to 80% across 6 sites).
13
Analyses of billing data from over 190,000 hospitalizations in 15 states in the United States indicate that the all-cause (i.e., for any reason) 30-day readmission rate is 20.5% (with considerable variation across hospitals). Only about 1 in 3 of such readmissions are related to COPD.
16 The majority of readmissions at 30 days appear to be related to deteriorations in co-existing conditions including cardiac, renal, and gastrointestinal disease, as well as concurrent infections (e.g., pneumonia).
16 These findings suggest the need for adequately addressing co-existing conditions in the hospital and in the post-hospital period.
Among patients hospitalized for COPD exacerbations, 
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The Five Hospital Readmissions Reductions Program PenaltySensitive Conditions
the risk of 30-day readmissions is higher among patients living in areas with lower income (1.4% absolute risk increase in patients living in the lowest versus highest quartile of household income) and among blacks (4%, 2.7%, and 2.6% higher compared to Asians/Pacific Islanders, Hispanics, and whites, respectively).
16 These findings suggest that reducing hospital readmissions will require not only improving access, quality, and coordination of care post-discharge, but also resources linked to socioeconomic status (e.g., affordability of out-of-pocket costs of prescription medications; availability of transportation to appointments after hospital discharge; Table 2 ). These considerations highlight the disproportionate challenges that hospitals serving vulnerable patient populations will face when implementing programs to reduce hospital readmissions.
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Including COPD in the Hospital Readmissions Reduction Program : The Upsides and Downsides
There are multiple benefits supporting the inclusion of COPD in the CMS HRRP. 52 Considering the growing clinical and financial impacts of COPD in the United States, many consider this new focus on COPD long overdue. Inclusion of COPD in the CMS HRRP has given hospitals a financial incentive to improve the care and outcomes of hospitalized patients with COPD exacerbations. In January 2013, CMS also introduced new billing codes for transitional care management, which could assist hospitals and clinicians in off-setting costs of developing and implementing strategies to improve care and outcomes after hospital discharge.
53
Additionally, the all-cause 30-day readmissions rate following COPD exacerbations could serve as an easy to measure key performance indicator for cross-hospital comparisons by patients, caregivers, and payers. However, use of 30-day all cause readmission rates after hospitalization as an accountability measure is also problematic. Of particular concern is the lack of a validated algorithm with high sensitivity and specificity using International Classification of Disease, Ninth Revision (ICD-9) codes to identify hospitalization for COPD exacerbations, 54 lack of evidence that decreasing readmissions improves outcomes (e.g., unintentional consequences include higher out-of-hospital mortality rates), and uncertainty regarding the preventability of readmissions. 55 There are other limitations to the use of the 30-day CMS readmissions measure. The methods used to calculate the expected readmission rate (which is used to determine if the 30-day readmissions rate is excessive) does not account for socioeconomic resources, which could adversely affect safety-net hospitals that provide a disproportionate share of care to patients with low socioeconomic resources. Financial penalties to safety-net hospitals could further diminish resources available to provide care to vulnerable populations. Also, the 30-day readmissions measure linked to 5 penalty-sensitive condition is susceptible to gaming -theoretically, hospitals could use diagnosis codes that avoid identifying the hospitalization as one for a penalty sensitive condition in patients at high-risk for a readmission. 
Evidence-Based Programs to Reduce Hospital Readmissions
General (Not Disease-Specific) Interventions
Much of the emphasis on reducing hospital discharge has been on the use of a bundle of medical interventions to improve the quality of hospital-based care and coordination of care with providers in the ambulatory setting. The care practices within the bundles include provider level interventions to increase adherence to evidence-based clinical practice guidelines (e.g., use of checklists), medication reconciliation, patient education, and arranging a follow-up visit with ambulatory providers and providing discharge summaries to improve hand-offs between hospital and ambulatory-based providers. BOOST engages a hospital-based multi-disciplinary quality improvement (QI) team to enhance the discharge process.
12,62-64 Members of the QI team are typically clinical and administrative leadership of the hospital, including nurses, case managers, social workers, physicians, pharmacists, QI analysts, information technology staff, administrative staff and outpatient providers. A BOOST mentor identified by SHM works with the hospital-based QI team to review the development and use of a universal discharge checklist to (1) reconcile medications; (2) educate patients and caregivers about diagnosis, prognosis, self-care requirements, action plan, medication and side effects, using teach back; (3) establish phone contact with the patient by a nurse or pharmacist (or less commonly, a physician); and (4) establish phone or other communication with the ambulatory care provider to arrange a "warm" hand-off. BOOST recommends a phone call with the patient within 72 hours of discharge to assess health status, promote adherence to the treatment plan, and remind about follow-up, and to communicate the discharge plan and any update to the plan via phone to the ambulatory provider. BOOST does not include home visits. Data from 11 hospitals which implemented 1 or more Project BOOST tools, demonstrated an absolute 30-day readmission reduction of 2% and a relative reduction of 13.6%. Project Red was developed at Boston University Medical Center to improve patient safety and reduce hospital readmission rates.
9,56 The RED intervention is founded on 12 discrete, mutually-reinforcing components, such as language assistance, making appointments and plans for follow-up care, organizing post-discharge services (e.g., medical equipment), reviewing medication prescriptions, educating patients about their diagnosis, medications, and action plan, calling patients within 72 hours of discharge by a discharge educator or other member of the clinical staff to reinforce the discharge plan, and facilitating communication with ambulatory providers. As with Project BOOST, Project RED does not include home visits. More than 500 hospitals, in 49 states and 9 countries, have downloaded the Project RED toolkit and nurse training manual. In a clinical trial of over 700 patients, patients assigned to Project RED (versus usual care) had a significantly lower rate of emergency department visits and hospitalizations within 30 days (incidence rate ratio 0.7, P=0.009).
56 Implementation of Project RED components in another setting was associated with a reduction of readmission rates (relative reduction: 36% at 30 days, compared to historical data).
66
The Transitional Care Model targets older adults with complex needs transitioning from an acute care setting to their home or other care setting, and aims to prepare patients and family caregivers to more effectively manage changes in health associated with multiple chronic illnesses. 10, 60, 61, 67, 68 A nurse serves as the primary care coordinator during the transition out of the hospital (Transitional Care Nurse) to coordinate individualized, patient-centered, multidisciplinary care that includes the following key elements: regular home visits for an average of 8 weeks after discharge, telephone support, engagement and education of patient and family, and communication between patient, caregivers, and health care providers, with emphasis on long term positive outcomes. Results of randomized clinical trials indicate that patients to the Transitional Care intervention have fewer readmissions (average relative reduction across studies: 45% at 90 days, 46% at 180 days, 36% at 12 months), fewer total days readmitted, lower mortality, and improved quality of life and patient satisfaction after discharge than patients receiving usual care. 61, 67, 68 The Care Transition Program is a 4-week program during which patients with complex care needs are supported by a coach (often a nurse practitioner or nurse skilled in geriatrics) and learn self-management skills to ensure their needs are met during the transition from hospital to home.
11 The program involves a predischarge visit in the hospital, a post-discharge home visit, and up to 3 follow-up phone calls at home. The program focuses on 4 concepts: (1) medication selfmanagement, (2) use of a dynamic patient-centered record, (3) primary care and specialist follow-up, and (4) 
11
In summary, these 4 programs can help to reduce unplanned readmissions by promoting adherence to evidence-based clinical practice guidelines, medication reconciliation, promoting patient self-management skills, and facilitating hand-offs during the transition from hospital to ambulatory-based care. BOOST, Project RED, Care Transitions Model, and the Transitional Care Model all include a phone call after discharge to assess adherence and complications. The Care Transitions Intervention and the Transitional Care Model also include nurse-led home visits to extend the period of hospital-based care into patients' homes.
However, none of these programs include interventions-specific to patients with COPD, such as how to teach self-management skills unique to patients with lung disease (e.g., inhaler technique; use of supplemental oxygen, participation in pulmonary rehabilitation) or addressing co-existing conditions that commonly complicate the management of patients with COPD (e.g., how to differentiate dyspnea from heart failure versus worsening COPD; how to address adverse effects of medications used to treat COPD exacerbations on co-existing conditions). While patients with COPD were included in the published studies evaluating the 4 programs, results were not presented stratified by diagnosis at the index hospitalization, so it is unclear if the overall intervention effects were also observed in patients hospitalized with COPD exacerbations.
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Interventions Specific to Patients With COPD Exacerbations
Systematic Review of Published Literature A recent systematic review 70 identified 5 randomized clinical trials evaluating interventions to reduce readmissions following COPD exacerbations.
71-75
These trials examined a range of different interventions, including discharge planning, disease education, health counseling, inhaler use teaching, development of an action plan, smoking cessation counseling, assessment of comorbidities, referral to pulmonary rehabilitation, use of a transition navigator, and follow-up home and/or telephone-based visits after discharge. Each study examined a different subset of the interventions above. Two of the 5 trials (1 conducted in Canada and 1 conducted in Spain and Belgium) showed a decrease in all-cause readmission over 12 months in the intervention group vs. comparator group (mean number of hospitalizations per patient: 1.0 vs. 1.8, P=0.01; percentage hospitalized: 45% vs. 67%, P=0.028, respectively).
72,74
The only clinical trial conducted in the United States found a greater than 2-fold higher risk of mortality in the intervention group (17% vs. 7%, P=0.003), but no significant difference in readmissions.
71 The other 2 trials failed to detect differences in readmission rates between groups. There was substantial heterogeneity in the design, measurement, and reporting of study results, precluding a formal meta-analysis. None of the trials were designed to examine the effects of care transition strategies on 30-day readmission rates; all focused instead on outcomes at 6 or 12 months. This review concluded that there is inadequate information to recommend COPD-specific interventions that can be used to reduce the risk of 30-day readmissions.
Unpublished Experience Various institutions are implementing strategies to reduce readmissions in patients hospitalized for COPD exacerbations. The Pittsburgh Regional Health Initiative in Pennsylvania conducted one of the nation's first regional collaboratives of medical, business and civic leaders organized to address health care safety and quality improvements. 76 In Phase 1, the program involved using an inpatient COPD nurse care manager to coordinate the care of patients with COPD upon discharge. To account for the significant overlap between the patients hospitalized with COPD and/or heart failure, the program evolved to create Primary Care Resource Centers (PCRC) in Phase 2. In Phase 2, the intervention involves a pharmacist for medication reconciliation, motivational interviewing, high-hazard medication focus and phone calls to patients within 72 hours of discharge, and nurse care managers to engage and educate patients and caregivers about self-management, conduct analysis of root cause for patients who are readmitted, and coordinate care with ambulatory providers. The program includes a home visit within 7 days of discharge and longitudinal care coordination. Compared to the period before implementation of the Phase 2 intervention, the post-implementation period was associated with a significant reduction in all-cause 180-day readmission rates (relative reduction approximately 47%). With the success of this first center, the health system received a $10.4 million award from the CMS Innovation Center to create 6 more PCRCs at community hospitals in Pennsylvania and West Virginia from 2012 to 2015.
The Jesse Brown Veterans Affairs Hospital in Chicago, Illinois implemented a Recovering Obstructive Lung Disease (ROLD) post-discharge clinic in 2013. The ROLD clinic consists of 3 outpatient visits over a 4-week period, with the first visit scheduled within 1 week of hospital discharge. The patient's first clinic visit is scheduled by the discharge team, prior to the patient's discharge from the hospital. The ROLD clinic is built on an integrated care clinic model, involving a team of physicians, nurses and nurse practitioners, palliative care specialists, social workers, and pharmacists. Key elements of the ROLD clinic include (1) a standardized history and physical examination, use of validated tools to assess patient-reported health (COPD Assessment Test), spirometry to confirm the COPD diagnosis and classify COPD severity , and evaluation of supplemental oxygen requirements at sleep, rest, and activity; (2) literacy-appropriate education (general disease education, trigger management, inhaler technique teaching, use of supplemental oxygen equipment); (3) optimization of medical therapy for COPD and medication reconciliation; (4) smoking cessation advice and referral to a smoking cessation clinic; and (5) coordination of referrals to pulmonary rehabilitation programs and other follow-up care. Compared to the 12 months prior to the ROLD clinic, the all cause 30-day readmissions rate for patients hospitalized with COPD exacerbations has dropped 5% (from 14%) according to a quality improvement report developed by Nina Bracken, APN, who provides care in the ROLD clinic.
Summary and Recommendations From the Summit
The COPD Readmissions Summit highlighted the significant implications of the recently expanded CMS efforts to reduce the risk of all-cause readmissions within 30-days of hospital discharge. Although some existing transitions of care programs have been successful at reducing all-cause readmissions, the applicability of such programs to patients with COPD exacerbations is unclear. Patients recovering from COPD exacerbations need interventions to promote self-management skills specific to COPD, address common co-existing clinical conditions that complicate COPD management, and coordinate care with ambulatory providers ( Figure  1 .) There is a surprising paucity of published evidence to guide clinicians and hospital administrators about how to safely avoid hospital readmissions in patients hospitalized for COPD exacerbations. The methods employed by the Pittsburgh Regional Health Initiative are promising; an evaluation when such strategies are scaled-up to other settings is needed. Discussions at the COPD Readmission Summit led to the following recommendations: 1) Programs to reduce hospital readmissions should include efforts to promote patient self-management skills specific to COPD, including appropriate use of medications (e.g., inhaler devices, supplemental oxygen), smoking cessation, and pulmonary rehabilitation. A rigorous evaluation of different approaches, including engaging caregivers, peers, and community health workers is needed.
2) Patients hospitalized with COPD exacerbations commonly have several clinically significant co-existing chronic and acute conditions (e.g., cardiovascular disease, pneumonia and mental health disorders). Results of studies suggest that co-existing disorders contribute to hospital readmissions more often than does a respiratory deterioration due to COPD. Strategies to reduce hospital readmissions in this population therefore need to adequately account for co-existing disorders during and after hospitalization.
3) Efforts to reduce hospital readmissions may be harmful. The only study conducted in the United States demonstrated excess risk of death in patients assigned to a comprehensive care management plan.
71
This observation highlights the need for appropriate monitoring of adverse events (including readmissions to other hospitals; out-of-hospital deaths) when implementing strategies to reduce hospital readmissions in patients recovering from COPD exacerbations.
4) A variety of hospital readmissions reduction programs are being implemented across the United States. A strategy to connect groups who are engaged in developing, testing, and implementing programs to reduce hospital readmissions is needed. The COPD Foundation has established a learning collaboratory to share best practices and to identify opportunities to inform the development of multicenter studies.
